Discovery Mood & Anxiety AI Visibility Market Strategy Report - Mental Health Treatment Centers

Answer Capsule

Discovery Mood & Anxiety is the only brand in the October 2026 Mental Health Treatment Centers benchmark to record a significant recommendation gain, rising from 0.0% valid recommendation coverage in July 2026 to 2.7% in October 2026. The brand now appears in a top-three recommendation position in 2.16% of qualified observations and holds a rank-one rate of 1.08%. Its clearest strength is momentum and positive framing, with a net sentiment score of 0.625 and zero negative mentions. Its clearest weakness is scale: five valid recommendations across 185 qualified observations, against a category leader at 78. Its clearest opportunity is converting a thin but real recommendation pocket into durable coverage before the category's larger brands reconsolidate.

Who This Report Is For

This report is written for Discovery Mood & Anxiety leadership, marketing and admissions strategy teams, and category analysts evaluating how adolescent and young adult mental health treatment providers are surfaced and recommended across AI search and assistant platforms.

Report Card

Executive Summary

Discovery Mood & Anxiety enters the October 2026 benchmark as the only brand in the tracked set to post a significant recommendation gain against the July 2026 baseline. Valid recommendation coverage rose from 0.0% in July 2026 to 2.7% in October 2026, a move of 2.7 percentage points that the benchmark classifies as beyond normal month-to-month variation. Raw mention presence rose from 0.0% to 4.3% over the same window, and top-three placement rose from 0.0% to 2.2%. Rank-one placement reached 1.1%.

The absolute base is thin. Five valid recommendations, four top-three placements, and two rank-one placements in October 2026 sit against a qualified observation base of 185. The brand's presence rate of 4.3% and valid recommendation coverage of 2.7% place it eighth of ten tracked brands on coverage, ahead of Acadia Healthcare at 1.1% and Newport Healthcare at 0.5%.

Framing quality is a genuine strength. Discovery Mood & Anxiety recorded five positive mentions, three neutral mentions, and zero negative mentions in October 2026, producing a net sentiment score of 0.625. That places it mid-pack on sentiment, below The Menninger Clinic at 0.975 and Sierra Tucson at 0.955, but above Rogers Behavioral Health at 0.679 and well above Acadia Healthcare and Newport Healthcare at 0.333 each.

The strongest platform signal is Google AI Overviews, where the brand recorded a 4.92% valid recommendation coverage rate and a 3.28% top-three rate. Copilot produced the only rank-one placements, with an 11.76% rank-one rate on a very small sample. ChatGPT, Gemini, and Perplexity returned no valid recommendations for the brand in October 2026.

The clearest gap is conversion. Discovery Mood & Anxiety appears in 4.3% of qualified observations but converts only 2.7% into valid recommendations, and its top-three rate of 2.16% trails its coverage rate. The brand is being surfaced more often than it is being shortlisted, and it is being shortlisted more often than it is being placed near the top.

The category context matters. McLean Hospital holds 42.2% valid recommendation coverage and a 21.7 percentage point lead over second-place Skyland Trail. Five brands declined beyond normal variation across the baseline window, and the category's recommendation-shaped answer share fell 3.9 points to 48.1%. Discovery Mood & Anxiety's gain is real but small against a category where the leader holds roughly sixteen times its coverage.

One factual conflict sits on the brand's two strongest platforms. ChatGPT and Copilot describe the Irving, Texas location at fundamentally different levels of care, both drawing on the brand's own domain.

What Discovery Mood & Anxiety Is Winning

Questions This Section Answers

• Where is Discovery Mood & Anxiety posting its only significant recommendation gain?
• How clean is the brand's sentiment record across the tracked platforms?
• Which platform surfaces are producing the brand's strongest recommendation signal?

The brand's clearest win is directional. Discovery Mood & Anxiety is the only tracked brand to record a significant upward move in valid recommendation coverage across the July to October 2026 window. Every other brand either declined beyond normal variation or held stable. That distinction matters because it establishes the brand as the category's only measurable riser at a moment when most of the field contracted.

The second win is framing quality. Zero negative mentions across 185 qualified observations is a clean record. The brand's net sentiment score of 0.625 reflects five positive and three neutral mentions, and it places the brand above Rogers Behavioral Health, Lindner Center of HOPE, Acadia Healthcare, and Newport Healthcare on framing. For a treatment category where cautionary or comparison-anchor framing is a real risk, a clean sentiment record is a meaningful asset.

The third win is platform concentration in a favorable surface. Google AI Overviews produced a 4.92% valid recommendation coverage rate for the brand, the highest single-platform coverage figure in its October 2026 profile. Copilot produced the brand's only rank-one placements, at an 11.76% rank-one rate on a two-observation base. These are narrow pockets, but they show the brand can reach first position on at least one surface.

The wins are real but small. Five valid recommendations is a thin base, and the brand's coverage sits well below the category's top five. The report states this plainly rather than overstating the momentum.

Where Discovery Mood & Anxiety Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Discovery Mood & Anxiety's mention presence convert into so few recommendations?
• Which platforms returned zero valid recommendations for the brand?
• How far behind McLean Hospital is Discovery Mood & Anxiety on recommendation scale?

The first gap is conversion efficiency. Discovery Mood & Anxiety's raw mention presence rate of 4.3% converts to a valid recommendation coverage rate of 2.7%, a conversion ratio of roughly 63%. McLean Hospital converts 54.6% presence into 42.2% coverage, a ratio of roughly 77%. Skyland Trail converts 25.9% presence into 20.5% coverage, a ratio of roughly 79%. The brand is being mentioned but not shortlisted at the rate its larger competitors achieve.

The second gap is top-three placement. The brand's top-three rate of 2.16% is below its coverage rate of 2.7%, which means some valid recommendations place the brand outside the top three positions. McLean Hospital's top-three rate of 39.5% sits close to its coverage rate of 42.2%, and Skyland Trail's 18.4% sits close to its 20.5%. Discovery Mood & Anxiety is being recommended, but not consistently near the top of the shortlist.

The third gap is platform absence. ChatGPT, Gemini, and Perplexity returned zero valid recommendations for the brand in October 2026. ChatGPT alone carried 21 qualified observations in the benchmark, and Gemini carried 18. Those are surfaces where the brand is effectively invisible at the recommendation stage. The brand's entire recommendation footprint sits on Google AI Overviews and Copilot.

The fourth gap is scale against the leader. McLean Hospital holds 78 valid recommendations against the brand's five. The category leader's coverage is roughly sixteen times the brand's. Even a doubling of the brand's current coverage would leave it well outside the top five.

The fifth gap is cluster concentration. All 185 qualified observations in October 2026 fell into the Brand Recommendation class. The Pricing & Value and Multi-Brand Comparison classes carried two observations each and remain too thin to support brand-level conclusions. Discovery Mood & Anxiety's recommendation pocket sits entirely within discovery and consideration prompts, with no measurable presence in pricing or head-to-head comparison prompts.

Biggest Opportunity

Questions This Section Answers

• How much could the brand increase its top-three footprint by closing the gap on Google AI Overviews and Copilot?
• Why is the citation layer already working even though recommendation placement lags?

The single biggest opportunity is converting the brand's existing mention presence into top-three recommendation placement on Google AI Overviews and Copilot, the two surfaces where it already has a foothold.

Discovery Mood & Anxiety appears in 4.3% of qualified observations but reaches a top-three position in only 2.16%. Closing that gap on the two platforms where the brand already registers would roughly double its top-three footprint without requiring new platform penetration. Google AI Overviews carried 61 qualified observations in the benchmark and produced the brand's strongest coverage signal at 4.92%. Copilot carried 17 qualified observations and produced the brand's only rank-one placements. These are the two surfaces where the brand's citation and answer layer is already working.

The opportunity is specific because the brand's own domain, discoverymood.com, ranks seventh among the top ten cited domains in the benchmark with 79 citations across seven platforms. The brand's public evidence layer is already being retrieved. The gap is in how that evidence converts into recommendation placement, not in whether the brand is findable.

Competitive Landscape

Questions This Section Answers

• Where does Discovery Mood & Anxiety rank against the other tracked mental health brands?
• Why is average recommended rank a strength even though overall placement frequency is weak?

McLean Hospital holds dominant recommendation power in the Mental Health Treatment Centers category, with Skyland Trail as the strongest challenger and Silver Hill Hospital and The Menninger Clinic forming a second tier. Discovery Mood & Anxiety sits in the lower tier on coverage but holds the category's only significant upward move.

Average recommended rank covers rank-eligible recommendations only.

Discovery Mood & Anxiety ranks eighth of ten on top-three rate and joint seventh on rank-one rate. Its average recommended rank of 2.00 is the second-strongest in the table, behind McLean Hospital at 1.67, which indicates that when the brand does receive rank credit, it tends to place near the top. The gap is not placement quality but placement frequency.

AI Response Inconsistency Alerts

Questions This Section Answers

• What conflicting information did ChatGPT and Copilot provide about the Discovery Mood & Anxiety Irving location?
• Why is the level-of-care conflict classified as critical, and where does it originate?

One critical factual inconsistency was detected for Discovery Mood & Anxiety across two AI platforms.

AI platforms provided conflicting information about the level of care offered at the Discovery Mood & Anxiety Program in Irving, Texas. When asked "What is the Discovery mood and anxiety Program Irving?", ChatGPT stated that the Irving center is a residential treatment program where patients live at the facility, citing the discoverymood.com Irving location page and describing it as an adolescent residential mental health treatment center. Copilot stated that the program offers outpatient and possibly intensive outpatient programs (IOP), not full hospitalization, citing a separate discoverymood.com Irving location page.

The conflict is classified as critical because a facility cannot be primarily residential, where patients live on site around the clock, and simultaneously an outpatient program where patients attend appointments and return home. The two claims describe fundamentally different levels of care, and a prospective patient or referring clinician relying on either answer alone would receive a materially different picture of what the Irving location provides.

The flagged source on the residential side is the discoverymood.com Irving location page, which states that the Irving center accepts patients 24/7 and provides separate residential care to adolescents of all genders. The outpatient-side response cites a different discoverymood.com Irving URL. Both platforms drew from the brand's own domain, which indicates the conflict originates in how the brand's location pages are structured and retrieved rather than in third-party misinformation.

This is the only critical or high-severity inconsistency detected for the brand in October 2026, and it involves ChatGPT and Copilot, the two platforms where the brand holds its strongest recommendation signal. The conflict sits directly on the surfaces where the brand's recommendation footprint is concentrated.

Prompt Evidence

Google AI Overviews / Brand Recommendation Prompt: "iop program" Result: Discovery Mood & Anxiety appeared in a valid recommendation position on Google AI Overviews, contributing to the brand's 4.92% coverage rate on that surface.

Copilot / Brand Recommendation Prompt: "best child psychiatric hospitals" Result: Discovery Mood & Anxiety reached a rank-one position on Copilot, one of two rank-one placements the brand recorded on that platform.

ChatGPT / Brand Recommendation Prompt: "residential treatment centers for bipolar disorder" Result: ChatGPT returned no valid recommendation for Discovery Mood & Anxiety, consistent with the brand's zero coverage on that platform in October 2026.

Google AI Overviews / Brand Recommendation Prompt: "teen outpatient" Result: The brand was surfaced in a discovery-stage prompt where its adolescent and young adult positioning is directly relevant, supporting its presence in the consideration cluster.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit. Map the exact prompts where Discovery Mood & Anxiety is mentioned but not shortlisted, and isolate the two-platform recommendation pocket on Google AI Overviews and Copilot.

Phase 2: Recommendation Readiness Plan. Prioritize the conversion gap between the brand's 4.3% presence rate and its 2.7% coverage rate, with a specific focus on top-three placement.

Phase 3: Owned Answer Layer Buildout. Resolve the residential versus outpatient conflict on the Irving location pages so ChatGPT and Copilot retrieve a single, consistent level-of-care description.

Phase 4: Citation / Authority Layer Development. Strengthen the discoverymood.com source footprint that already ranks seventh among cited domains, and extend it to the platforms where the brand is currently absent.

Phase 5: Monthly AI Visibility and Recommendation Tracking. Track whether the 2.7% coverage persists across a second month, whether top-three placement closes the gap to coverage, and whether the brand's rank-one placements on Copilot expand or remain isolated.

Why This Matters

AI presence alone is not enough. Discovery Mood & Anxiety appears in 4.3% of qualified observations but converts only 2.7% into valid recommendations, and its top-three rate of 2.16% trails its coverage rate. The brand is being found without being consistently chosen, and in a category where McLean Hospital holds a 21.7 percentage point lead, the difference between being mentioned and being recommended is the difference between being on the buyer's radar and being on the buyer's shortlist.

The next move is targeted correction of the prompt, page, and citation layers. The brand's own domain already carries meaningful citation weight in this vertical, and its only significant recommendation gain in the benchmark came from a thin but real pocket on Google AI Overviews and Copilot. The work is to widen that pocket, resolve the level-of-care conflict that sits directly on those surfaces, and convert existing mention presence into top-three placement before the category's larger brands reconsolidate.

Core Metrics

Sentiment Score

Questions This Section Answers

• How many of Discovery Mood & Anxiety's mentions carried no positive recommendation signal?
• Why does a brand's raw mention count matter less than its classified sentiment breakdown?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Discovery Mood & Anxiety in October 2026, that is (5 × 1 + 3 × 0 + 0 × -1) / 8, which equals 0.625.

This matters because unclassified mention counts are misleading. A brand with eight mentions and no sentiment breakdown looks identical whether those mentions are strong recommendations, neutral references, or cautionary comparisons. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement.

Discovery Mood & Anxiety's 0.625 score reflects a clean record with no negative framing, but it also reflects a small sample. Three of the brand's eight mentions are neutral, which means nearly 38% of its mentions carry no positive recommendation signal. Classified sentiment is required before interpreting AI visibility, and for a brand operating on a five-recommendation base, the distinction between a positive recommendation and a neutral reference is the difference between a shortlist placement and a passing mention.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Discovery Mood & Anxiety's AI recommendation footprint in the Mental Health Treatment Centers category. It is not a client implementation case study and does not imply that any remediation work produced the observed results.
2. The reporting month is October 2026, with comparison points at July 2026, August 2026, and September 2026.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The October 2026 benchmark collected 594 prompt-surface observations across 364 unique questions. Of those, 441 were relevant and 153 were irrelevant, producing 185 qualified observations used as the public denominator.
5. The competitor universe contains ten tracked brands: Acadia Healthcare, Discovery Mood & Anxiety, Lindner Center of HOPE, McLean Hospital, Newport Healthcare, Rogers Behavioral Health, Sierra Tucson, Silver Hill Hospital, Skyland Trail, and The Menninger Clinic.
6. Three public high-intent clusters were defined. Only the Brand Recommendation cluster, covering discovery and evaluation prompts, returned sufficient observations in October 2026. The Pricing & Value and Multi-Brand Comparison clusters carried two observations each and remain too thin to support brand-level conclusions.
7. Stage 0 extraction captured the query, AI or search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources.
8. A mention is counted when Discovery Mood & Anxiety appears in a qualified observation in any capacity, including neutral reference and comparison-anchor appearances.
9. A valid recommendation is counted only when the brand appears in a valid recommendation shortlist as marked by the dataset. Negative, neutral, cautionary, and listed-only mentions are not counted as valid recommendations.
10. Top-three rate and rank-one rate are calculated within the qualified observation set, not the raw collection universe.
11. Average recommended rank covers rank-eligible recommendations only. Brands with no rank-eligible recommendations are marked N/A.
12. Several brands in this vertical operate on small absolute counts. Discovery Mood & Anxiety's five valid recommendations, four top-three placements, and two rank-one placements should be read with that limitation in mind. Percentage movements on bases this thin are directional rather than definitive.
13. The benchmark identifies movement worth investigating. It does not establish cause. A change in recommendation coverage can reflect AI system behavior, underlying source material, prompt composition, or measurement effects that the public benchmark cannot separate.

See How AI Is Recommending Your Brand

The public benchmark shows where Discovery Mood & Anxiety is gaining and where it is being displaced. A company-level AI visibility audit maps the prompt, surface, competitor, ranking, sentiment, and evidence-source patterns behind those numbers into a prioritized strategy, including the level-of-care conflict currently appearing across ChatGPT and Copilot.